(6-chloro-1-(4-methoxyphenyl)-3,4-dihydro-1H-pyrido[3,4-b]indol-2(9H)-yl)(2-methoxyphenyl)methanone

ID: ALA4540234

PubChem CID: 117937359

Max Phase: Preclinical

Molecular Formula: C26H23ClN2O3

Molecular Weight: 446.93

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C2c3[nH]c4ccc(Cl)cc4c3CCN2C(=O)c2ccccc2OC)cc1

Standard InChI:  InChI=1S/C26H23ClN2O3/c1-31-18-10-7-16(8-11-18)25-24-19(21-15-17(27)9-12-22(21)28-24)13-14-29(25)26(30)20-5-3-4-6-23(20)32-2/h3-12,15,25,28H,13-14H2,1-2H3

Standard InChI Key:  LQKXDIOMYMGPQR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 36  0  0  0  0  0  0  0  0999 V2000
   42.4042   -3.8141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1054   -3.3983    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   43.0936   -2.5825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.3806   -2.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4157   -4.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7118   -5.0464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7221   -5.8628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.4356   -6.2629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1402   -5.8407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.1264   -5.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6958   -3.4187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6811   -2.6065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9279   -3.6836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.4385   -3.0352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9042   -2.3722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5627   -1.6395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.7559   -1.5687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2916   -2.2365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6357   -2.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8184   -3.7976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.8291   -4.6147    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.4474   -7.0800    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.7457   -7.4988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4093   -0.8286    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   44.5207   -3.3798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2299   -3.7804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.9318   -3.3633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.9215   -2.5453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2035   -2.1462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.5047   -2.5657    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.2389   -4.5976    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   45.9511   -4.9984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12  4  1  0
 11  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  1  5  1  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
 13 11  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  2 20  1  0
 20 21  2  0
  8 22  1  0
 22 23  1  0
 17 24  1  0
 20 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 26 31  1  0
 31 32  1  0
M  END

Associated Targets(non-human)

Human gammaherpesvirus 4 (1538 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.93Molecular Weight (Monoisotopic): 446.1397AlogP: 5.63#Rotatable Bonds: 4
Polar Surface Area: 54.56Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.13CX LogD: 5.13
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -0.83

References

1. Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed FS, Reddy PAN, Kenney SC, Lieberman PM, Salvino JM..  (2019)  Development of a novel inducer for EBV lytic therapy.,  29  (16): [PMID:31255485] [10.1016/j.bmcl.2019.06.034]

Source